title: Small-molecule modulators for epigenetics targets.
abstract: A capital conference: Influencing epigenetic mechanisms may be highly relevant for future therapies of various diseases such as cancer, inflammation, and metabolic disorders. Leading experts in the field gathered in Berlin on June 5-6, 2013 at a Bayer HealthCare Life Science Workshop to share recent success stories and to discuss future trends.
authors.affiliation: Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building and Target Discovery Institute, Roosevelt Drive, Headington, Oxford, OX3 7FZ (UK).
authors.forename: Stefan
authors.initials: S
authors.lastname: Knapp
authors.forename: Hilmar
authors.initials: H
authors.lastname: Weinmann
mesh_terms: D016503:Drug Delivery Systems; D044127:Epigenesis, Genetic / Q000187:drug effects*; D000076983:Histone Methyltransferases; D011495:Histone-Lysine N-Methyltransferase / Q000737:chemistry; D006801:Humans; D015394:Molecular Structure; D054852:Small Molecule Libraries / Q000737:chemistry* / Q000494:pharmacology*
chemical_list: D054852:Small Molecule Libraries; D000076983:Histone Methyltransferases; D011495:Histone-Lysine N-Methyltransferase
keywords: bromodomains; cancer; chemical probes; epigenetic targets; histone methyltransferase; inhibitors